I'd personally be content with that rather than happy. Primarily because i'm assuming that with less accuracy the medical community, insurers, general population etc will be less likely to take it up.
Is there a concern that given the accuracy with less than 4 applications / usages of the technology was <70% that it won't even get FDA approval?
Ann: Clinical Study Shows Improvement to Diagnostic Standard, page-19
-
- There are more pages in this discussion • 42 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add TRI (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.9¢ |
Change
-0.001(5.00%) |
Mkt cap ! $8.683M | |||
| Open | High | Low | Value | Volume |
| 1.9¢ | 1.9¢ | 1.8¢ | $57.01K | 3.140M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 450000 | 1.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.2¢ | 203847 | 2 |
View Market Depth
| Last trade - 15.21pm 04/10/2024 (20 minute delay) ? |
| TRI (ASX) Chart |